Diabetic Retinopathy (DR) is a leading cause of visual impairment globally and the prevalence of Diabetes Retinopathy is increasing at an alarming rate and is more prevalent in working age adults. Globally the prevalence of any DR among diabetes was estimated as 34.6%, while the prevalence for proliferative DR was 6.9% and for diabetic macular edema was 6.81%. The overall prevalence of vision-threatening DR (VTDR) was estimated to be 10.2% .These figures translate to 93 million persons with DR and 28 million with VTDR in a global context.
Compounding this global challenge of diagnosis and treating of DR among people with diabetes, further is the fact that there are estimated 175 million people with diabetes who are undiagnosed and therefore not aware of their health condition including getting their eye examinations to rule out the presence of its most complication such as DR.
As per study done by Gilbert C, et al. on Eye Care infrastructure and human resources for managing diabetic retinopathy in India: currently there are 65 million people who are known diabetics and at least 10 % of these are likely to have sight threatening diabetic retinopathy which means that approximately 6,500,000 people with diabetes need a confirmatory diagnosis, treatment and follow –up.
Delivering ophthalmic care at the appropriate time to people with diabetes can become a potential cost effective approach with huge cost saving besides reducing the suffering caused by blindness and vision impairment due to Diabetic Retinopathy.
To address and control blindness arising out of diabetic retinopathy, Sankara initiated the Diabetic Retinopathy Program (DRP) with the following objectives:
Eye Care Beyond Compare
WORLD-CLASS FACILITIES WITH A SOCIAL IMPACT